Ozempic and Wegovy linked to rare blindness risk, study finds
27
votes
Showing only topics with the tag "wegovy".
Back to normal view
-
-
Novo Nordisk is to invest more than $4bn in US manufacturing as it battles to keep up with booming demand for its obesity and diabetes drugs Wegovy and Ozempic
9 votes -
Can Denmark's world-beating drugs maker Novo Nordisk stay ahead after Wegovy propelled them into the big league?
8 votes -
Novo Nordisk suggested to senior UK government officials that they could “profile” benefit claimants – those who are most likely to return to the labour market
17 votes -
Something is golden in the state of Denmark – can Novo Nordisk's success really be a problem for the Danish economy?
8 votes -
Novo Nordisk, the maker of weight-loss drug Wegovy has become Europe's most valuable firm, dethroning the French luxury conglomerate LVMH
20 votes -
Novo Nordisk, the Danish company behind two popular obesity medications, is reaping huge profits and is now responsible for most of the country's economic growth
6 votes -
Wegovy may be valuable new option for heart failure patients
6 votes -
America's obsession with weight-loss drugs is affecting the economy of Denmark – Novo Nordisk's market capitalization has matched the GDP of its home country
17 votes -
Most patients using weight-loss drugs like Wegovy stop within a year, data show
10 votes -
US medical insurers clamping down on doctors who prescribe Ozempic for weight loss
22 votes